Pycnogenol® (bark extract from pinus pinaster) uses in prevention and treatment of cardiopathies

Revista de Medicina da UFC

Endereço:
Gerência de Ensino e Pesquisa - Universidade Federal do Ceará/Rua Coronel Nunes de Melo, S/N - Bloco dos ambulatórios (ilhas) - Andar superior - Rodolfo Teófilo
Fortaleza / CE
60430-270
Site: http://periodicos.ufc.br/revistademedicinadaufc
Telefone: (85) 3366-8590
ISSN: 24476595
Editor Chefe: Renan Magalhães Montenegro Júnior
Início Publicação: 30/11/2014
Periodicidade: Trimestral
Área de Estudo: Medicina

Pycnogenol® (bark extract from pinus pinaster) uses in prevention and treatment of cardiopathies

Ano: 2019 | Volume: 59 | Número: 3
Autores: Lucas Soares Bezerra, Natanael da Silva Bezerra-Junior, Marcelo Antônio Oliveira Santos-Veloso, Fernando de Oliveira, Ândrea Virgínia Chaves-Markman
Autor Correspondente: Lucas Soares Bezerra | [email protected]

Palavras-chave: pinus, heart diseases, antioxidants

Resumos Cadastrados

Resumo Inglês:

Pycnogenol® (Pyc) is an extract from a plant bark known as Pinus pinaster. Some studies have shown that Pyc can prevent oxidative damage, inhibit inflammatory cytokines and be used in the treatment of metabolic syndrome. This study aimed to review the state of the art of Pyc in the treatment of cardiovascular disease. The keywords “pycnogenol” and “cardiopathy” were searched on the PubMed, Scopus, The Cochrane Library, Scielo and Bireme databases. Studies involving animals or with no relation to cardiological conditions were excluded. The findings in the literature point Pycnogenol® as a promising substance in the treatment of cardiovascular conditions, as well as in other medical situations. Some studies have showed benefits in reduction of antihypertensive drugs dose and collateral effects, better control of diabetes, and reduction of cardiovascular risk factors. However, these results were obtained from studies with small sample of patients, limited follow-up and important biases. Further studies such as larger clinical trials are needed to elucidate the real risk-benefit of Pycnogenol® on treatment of cardiovascular diseases.